BLS Polymers IPO GMP Signals Strong Listing Gain Hopes

GMP points to active listing expectations

BLS Polymers IPO has drawn attention across social-media IPO trackers because of its grey market premium, or GMP. The issue opened for subscription on October 27, 2026, and closed on October 29, 2026. Its tentative listing date is November 3, 2026, on the BSE and NSE. The upper end of the price band is ₹150 per share. The reported lot size is 100 shares. That makes the application value at the upper band ₹15,000 for one retail lot. GMP-based calculators are indicating possible listing gains, not confirmed returns. Investors should treat all such projections as unofficial market sentiment rather than an exchange-backed price signal.

Latest GMP reports show a wide range

GMP figures quoted in the available discussions vary by source and update time. The latest reported figure was ₹68 at 9:30 pm IST on October 29. That reading implied a potential listing price of ₹218 per share. It represented a 45.3% premium to the ₹150 issue price. Other updates on October 29 showed GMP readings of ₹60, ₹62 and ₹63. Those figures indicated estimated listing prices between ₹210 and ₹213. Earlier tracker updates cited a GMP of ₹51 and an estimated listing price of ₹201. The variation shows why a single GMP number should not be treated as a fixed listing forecast.

What the reported figures imply

The calculation used by IPO trackers is straightforward. They add the reported GMP to the upper issue price of ₹150. A ₹68 GMP produces an indicative price of ₹218. A ₹63 GMP points to about ₹213. A ₹60 GMP points to about ₹210. A ₹51 GMP points to about ₹201. These are estimates based on the grey market, not prices determined by BSE or NSE trading. The actual opening and listing-day price can differ significantly from these calculations.

GMP movement reported before the close

The available updates suggest that sentiment strengthened over the subscription period. On October 26, a tracker reported a GMP of ₹40. That level indicated an estimated listing price of ₹190, or a 26.67% gain. GMP was reported at ₹44 on October 27 and October 28. The ₹44 reading implied a projected price of ₹194 and a 29.33% gain. Subsequent October 29 reports ranged from ₹51 to ₹68. This progression is a record of reported unofficial quotes, not a regulated price history. Grey market premiums can change quickly before listing.

Indicative returns for one retail lot

At the ₹150 upper price band, one lot of 100 shares requires ₹15,000. A GMP of ₹51 would imply an indicative profit of ₹5,100 before charges and taxes. At a GMP of ₹60, the comparable estimate rises to ₹6,000. A ₹62 GMP would imply ₹6,200 for one lot. A GMP of ₹63 would imply ₹6,300. At the highest reported GMP of ₹68, the estimated gain would be ₹6,800. These figures use the formula of GMP multiplied by the 100-share lot size. They assume allotment and a listing price matching the GMP-based estimate, neither of which is assured.

Issue terms and expected timetable

BLS Polymers IPO has a price band of ₹142 to ₹150 per share. The issue size cited in the discussion is ₹255 crore. The lot size is 100 shares. The subscription window ran from October 27 through October 29, 2026. Shares are tentatively scheduled to list on November 3, 2026. The stated listing venues are BSE and NSE. Dates related to allotment, refunds, demat credit and listing are described as tentative. Investors should therefore track official notices for final timelines.

Financial detail cited in IPO discussions

The context cites an increase in BLS Polymers' revenue between the financial years ended March 31, 2025 and March 31, 2026. Revenue was said to have increased by 5% over that period. Profit after tax was said to have risen by 28%. The available discussion does not provide the underlying revenue or profit figures. It also does not provide valuation metrics or subscription-category data. Those missing details limit any broader fundamental assessment from the supplied information. The reported GMP is mainly a measure of pre-listing sentiment. It should not be used as a substitute for evaluating the company and offer documents.

Why the actual listing can differ

GMP trades occur in an unofficial grey market. They are not regulated by stock exchanges. They are also not a guarantee of allotment, listing price or post-listing performance. Multiple sources in the discussion explicitly state that GMP may fluctuate before listing. One source described the figure as a rumour-based indicator. The reported range of ₹40 to ₹68 itself illustrates this volatility. A strong GMP can signal demand expectations, but the market price on November 3 will be set through actual exchange trading. Investors considering the issue should distinguish clearly between an indicative calculation and a realised return.

Key point for BLS Polymers IPO investors

BLS Polymers IPO entered its expected listing phase with reported GMP figures higher than the earlier ₹40 and ₹44 readings. The latest cited figure of ₹68 suggests an indicative price of ₹218. That would represent a 45.3% gain over the ₹150 upper price band. However, other October 29 reports placed the GMP between ₹51 and ₹63. Their projected listing prices ranged from ₹201 to ₹213. The range highlights the need to watch the timestamp and source behind every GMP quote. With listing tentatively set for November 3, official exchange trading will provide the definitive price. Until then, GMP-based gains remain estimates only.